Responding To Adam Feuerstein On Afrezza (by Joe Springer)
|
1
|
Mannkind
|
Apr 17, 2013 01:19PM
|
Risks MannKind Investors Need to Know
|
|
Mannkind
|
Jan 05, 2013 09:54AM
|
Roundtable: 5 Disruptive Technologies Leading the Next Medical Revolution
|
3
|
Mannkind
|
Feb 26, 2013 03:36PM
|
Rthargrave
|
2
|
Mannkind
|
Aug 29, 2012 11:31AM
|
Russia finalises international tests of insulin’s new form – inhalation
|
|
Mannkind
|
Jul 17, 2012 01:27PM
|
S-8
|
|
Mannkind
|
Jun 29, 2012 04:29PM
|
Say it isn't so
|
1
|
Mannkind
|
May 14, 2012 12:07PM
|
SCN Featured Stock Updates: CALL, MNKD and CRAY
|
|
Mannkind
|
Sep 19, 2012 04:01PM
|
Seeking Alpha article
|
|
Mannkind
|
May 07, 2013 04:07PM
|
Sentiment Drives MannKind to Fresh Highs Ahead of Vital Catalyst
|
|
Mannkind
|
May 28, 2013 10:49AM
|
September 13th Options Now Available For MannKind (MNKD)
|
|
Mannkind
|
Aug 15, 2013 02:01PM
|
September 21st Options Now Available For MannKind Corp (MNKD)
|
|
Mannkind
|
May 31, 2013 08:56AM
|
September 8-10
|
1
|
Mannkind
|
Jul 24, 2013 11:20AM
|
Short Sellers Think These 7 Biotech Stocks Have More Upside
|
2
|
Mannkind
|
Dec 07, 2012 03:36PM
|
Should MannKind Investors Bank on a Partnership?
|
|
Mannkind
|
Feb 21, 2013 03:03PM
|
Social Networking Stocks Faltering And The Volatile Biotechs
|
2
|
Mannkind
|
Jun 04, 2013 11:00AM
|
Somewhat OT:A Biotech Billionaire's Latest Drug Bet Implodes
|
|
Mannkind
|
Mar 26, 2013 12:26PM
|
Star Canada stockpicker runs year's top U.S. bond fund
|
|
Mannkind
|
Apr 15, 2013 01:34PM
|
Starting Insulin for Type 2 Diabetes: When, Why,
|
1
|
Mannkind
|
Jun 30, 2013 12:30PM
|
Statement of changes in beneficial ownership of securities
|
|
Mannkind
|
May 21, 2012 09:54PM
|